Subungual melanoma which appears under fingernails and toenails, is a rare but serious form of skin cancer that typically isn ...

Brian Gemmell, a fitness instructor, said he only had an odd swelling in his fingertips before his doctor diagnosed him with ...

Well-recognised signs of the deadly disease include a persistent cough and breathlessness, but experts have now flagged a ...

This week is Lung Cancer Action Week, and the American Lung Association is raising awareness of lung cancer and encouraging Louisiana residents to take action to help end the disease. Lung cancer is ...

Breast cancer is the second leading cause of cancer death in women. (Only lung cancer kills more women each year.) The chance that any woman will die from breast cancer is about 1 in 43 (about 2.3%).

Next week, the American Lung Association in Florida is turning Jacksonville turquoise to raise awareness about lung cancer, honor those impacted and encourage residents to take action to help end the ...

That’s the number of people in the U.S. who die from lung cancer each year. Accounting for about 1 in 5 of all cancer deaths, lung cancer kills more people each year than breast, colon, and prostate ...

The test processes whole-slide images of non-small cell lung cancer tissue to provide a quantitative TROP2 score, which Roche says provides a level of precision beyond manual methods. TROP2 has ...

Mike Peters, frontman of Welsh rock band the Alarm, who became as known for his three-decade struggle with cancer and fundraising efforts to combat the disease, has died, according to the BBC.

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access. In this clip, Raymond Osarogiagbon, MD ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2-mutant non-small cell lung cancer (NSCLC) in a multicohort phase Ia/Ib ...

while a smaller number experienced more serious lung infections and encephalitis. Diaz is hopeful dostarlimab will become an available option for the small number of cancer patients with mismatch ...